AKT1 and colon adenocarcinoma: Moreover, KYNA in a dose-dependent manner inhibited phosphorylation of Akt in colon adenocarcinoma HT-29 cells, the main element of PI3K/Akt pathway whose disturbance may lead to cancer promotion and progression [99].